Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Debate Resolved on Human Cell Shut-Down Mechanisms

By BiotechDaily International staff writers
Posted on 25 Apr 2012
Researchers have resolved the controversy over the mechanisms involved in the shutdown process during cell division in the body.

The investigators, from the University of Liverpool (UK), published their findings April 2012 in the journal Proceeding of the National Academy of Sciences of the USA (PNAS), may contribute to future research on how scientists could modify this shut-down process to ensure that viruses and other pathogens do not enter the cells of the body and cause harm.

Earlier studies had shown that when cells divide, they cannot execute any other task apart from this one. They cannot, for example, take in food and fluids at the same time as managing the important process of dividing into “daughter cells” to replicate the body’s genetic data. Instead, cells, shut-down the intake of food and fluid during cell division, and for many years it was thought that they did this by preventing a receptor from moving nutrients through the cell membrane.

Recently, scientists have provided evidence to suggest that this hypothesis may be wrong. Scientists have contended that the cell does not shut down the processes that allow food and fluid to enter the cell as previously believed, but rather the receptors that transport this fuel are absent altogether during cell division, allowing the cell to focus on the one task of dividing.

Studies at Liverpool, however, have now shown that the original concept, first documented in 1965, is accurate. The receptors are present and able to transport food and fluid during cell division, but the mechanism that allows them through the membrane of the cell shuts-down until cell division is complete.

Dr. Stephen Royle, from the University’s Institute of Translational Medicine, explained, “We know that cells in the body do not have the ability to multitask during cell division. It can only focus on the job of dividing and not on other important tasks such as uptake of nutrients. If we think of the cell membrane like a dock at a port and the receptors as a boat delivering cargo, we have shown that the boat, or receptor, is present but the dock, or membrane, does not allow it to unload or go any further. Viruses and pathogens use the same route into cells as nutrients, so the next stage of this work is to identify the trigger for this shutdown process, so that we understand whether this on/off switch can be manipulated to prevent harmful infections passing through the cell membrane. This is a long way in the future, but this work puts us closer to understanding how the cells in the body work.”

Related Links:

University of Liverpool



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.